Advertisement
U.S. markets close in 30 minutes
Advertisement

Yunkang Group Limited (2325.HK)

HKSE - HKSE Delayed Price. Currency in HKD
11.980+0.080 (+0.67%)
At close: 04:08PM HKT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close11.900
Open11.920
Bid11.880 x N/A
Ask12.020 x N/A
Day's Range11.880 - 11.980
52 Week Range11.780 - 17.200
Volume95,000
Avg. Volume190,252
Market Cap7.443B
Beta (5Y Monthly)N/A
PE Ratio (TTM)36.30
EPS (TTM)0.330
Earnings DateN/A
Forward Dividend & Yield0.31 (2.59%)
Ex-Dividend DateJul 04, 2023
1y Target Est16.11
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for 2325.HK

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • PR Newswire

      Yunkang Group Announces First Annual Results Since Listing

      Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325.HK), a leading medical operation services provider in China, has announced its first annual results for the year ended December 31, 2022 (the "Reporting Period") since its listing.